Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MNI

MNI
2000 FOUNDED
M&A STATUS
91-100 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of neurological imaging and drug development services. The company is a neuroimaging services company specializing in the efficient application of scintigraphic biomarkers in drug development and clinical research for neurodegenerative and neuropsychiatric disorders.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Monitoring Equipment
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 60 Temple Street 8A
  • New Haven, CT 06510
  • United States

+1 (203) 000-0000

MNI Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MNI‘s full profile, request access.

Request full access to PitchBook

MNI Executive Team (3)

Name Title Board
Seat
Contact
Info
John Seibyl President & Co-Founder
Kenneth Marek Senior Scientist & Founder
Rebecca Ervin Vice President, Operations